To cite this paper use one of the standards below:
Abelson kinase (Abl) is a tyrosine kinase involved in crucial cellular functions, such as actin polymerization and DNA damage responses. While its inhibition has been extensively studied due to its overactivation being linked to chronic myeloid leukemia (CML), recent research highlights the therapeutic potential of Abl activation. Activators of this kinase could be used to treat chemotherapy-induced neutropenia, mammary tumor, and prostate cancer. Abl is regulated by the binding of a myristoyl group to an allosteric site, enabling the enzyme's transition between active and inactive forms, and compounds binding to this site can promote either the activation or inhibitions of the Abl. A series of aminopyrazoles, recently studied by Simpson and collaborators, demonstrated to activate Abl through this mechanism. Herein, we used this data combined with molecular modeling approaches to characterize possible pharmacophoric models for Abl kinase activation. The structures of the activators were initially drawn using Chemsketch and subsequently optimized in Orca employing the AM1 semiempirical method. Ligand and receptor preparations were executed with AutoDockTools. Molecular docking procedures were conducted using Autodock Vina and validated through both redocking and cross-docking strategies. The RMSDs of the optimal poses of the compounds were compared with those of the crystallized compounds from PDB codes 6NPE and 6NPU. Interaction analyses were carried out using PLIP software. Interactions from the protein's perspective reveal that hydrophobic interactions were the most prevalent, primarily concentrated around residues Tyr 454, Leu 360, Pro 484, Leu 359, Val 487, and Ala 452. Hydrogen bonds were observed with the protein as the donor at residues Tyr 454, Ala 452, Arg 351, and Ala 336. As acceptors of hydrogen bonds, the protein showed interactions at residues Tyr 454, Ala 452, Glu 481, and Gly 482. Additionally, halogen-mediated hydrogen bonds were observed, with Leu 448 being the sole residue involved, showing an average distance of 3.4 Å. Analysis of the data identified crucial residues involved in the binding of Abl activators to the myristoyl site, contributing to the construction of a pharmacophoric model. This model can be leveraged in virtual screening to identify and select potential new candidates for Abl activation.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper